| Ticker Details |
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$75.11B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.40 | 1.43%
|
| Avg Daily Range (30 D): |
$0.67 | 1.45%
|
| Avg Daily Range (90 D): |
$0.93 | 1.77%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
10.05M |
| Avg Daily Volume (30 D): |
15.81M |
| Avg Daily Volume (90 D): |
16.76M |
| Trade Size |
| Avg Trade Size (Sh.): |
237 |
| Avg Trade Size (Sh.) (30 D): |
114 |
| Avg Trade Size (Sh.) (90 D): |
113 |
| Institutional Trades |
| Total Institutional Trades: |
111,303 |
| Avg Institutional Trade: |
$3.48M |
| Avg Institutional Trade (30 D): |
$5.25M |
| Avg Institutional Trade (90 D): |
$5.48M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$31.42M |
| Avg Closing Trade (30 D): |
$105.23M |
| Avg Closing Trade (90 D): |
$129.78M |
| Avg Closing Volume: |
753.91K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$2.49
|
$.62
|
$.9
|
|
Diluted EPS
|
$2.47
|
$.61
|
$.9
|
|
Revenue
|
$21B
|
$5.44B
|
$5.2B
|
|
Gross Profit
|
$14.68B
|
$3.85B
|
$3.61B
|
|
Net Income / Loss
|
$3.67B
|
$905M
|
$1.34B
|
|
Operating Income / Loss
|
$4.15B
|
$1.18B
|
$1.1B
|
|
Cost of Revenue
|
$6.32B
|
$1.59B
|
$1.59B
|
|
Net Cash Flow
|
$12M
|
$-891M
|
$-503M
|
|
PE Ratio
|
|
|
|
|
|
|
